Evidence map›Paper›PMID 33063159›Full record

ArticleActa neurochirurgica2022

Extensively drug-resistant and multidrug-resistant gram-negative pathogens in the neurocritical intensive care unit.

Marina Munari, Francesca Franzoi, Massimo Sergi, Alessandro De Cassai, Federico Geraldini, Marzia Grandis, Massimiliano Caravello, Annalisa Boscolo, Paolo Navalesi

Abstract read
PubMed Publisher
In one paragraph

Article in Acta neurochirurgica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Multidrug-Resistant Bacteria in Immunocompromised Patients.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Marina MunariUOC Anaesthesia and Intensive Care Unit, University Hospital of Padua, via Giustiniani 2, 35128, Padua, Italy.
Francesca FranzoiUOC Anaesthesia and Intensive Care Unit, University Hospital of Padua, via Giustiniani 2, 35128, Padua, Italy.
Massimo SergiUOC Anaesthesia and Intensive Care Unit, University Hospital of Padua, via Giustiniani 2, 35128, Padua, Italy.
Alessandro De CassaiUOC Anaesthesia and Intensive Care Unit, University Hospital of Padua, via Giustiniani 2, 35128, Padua, Italy. alessandro.decassai@aopd.veneto.it.ORCID http://orcid.org/0000-0002-9773-1832
Federico GeraldiniUOC Anaesthesia and Intensive Care Unit, University Hospital of Padua, via Giustiniani 2, 35128, Padua, Italy.
Marzia GrandisUOC Anaesthesia and Intensive Care Unit, University Hospital of Padua, via Giustiniani 2, 35128, Padua, Italy.
Massimiliano CaravelloUOC Anaesthesia and Intensive Care Unit, University Hospital of Padua, via Giustiniani 2, 35128, Padua, Italy.
Annalisa BoscoloUOC Anaesthesia and Intensive Care Unit, University Hospital of Padua, via Giustiniani 2, 35128, Padua, Italy.
Paolo NavalesiUOC Anaesthesia and Intensive Care Unit, University Hospital of Padua, via Giustiniani 2, 35128, Padua, Italy.
University of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAbrupt increase of multidrug-resistant, extensively drug-resistant, and pandrug-resistant bacteria may complicate the course, management, and costs of neurocritical patients and is associated with high morbidity and mortality rates. No data exists regarding risk factors for colonization by gram-negative pathogens in neurocritical patients. The aim of the study was to identify risk factors associated with colonization by multidrug-resistant, extensively drug-resistant, and pandrug-resistant gram-negative bacteria in neurocritical patients.

methodsWe conducted a retrospective cohort study in a neurointensive care unit over a period of 3 years. We included adult neurocritical patients admitted for more than 48 h. We analyzed several factors including both anamnestic factors and admission diagnosis.

resultsFour hundred twenty neurocritical patients were retrospectively enrolled. Seventy-three patients developed colonization by multidrug-resistant and 53 by extensively drug-resistant gram negative pathogens. Logistic regression identified intensive care unit length of stay (LOS) as the strongest predictor for both multidrug-resistant (AUC 0.877; 95% CI 0.841-0.913) and extensively drug-resistant (AUC 0.839 0.787-0.892) gram negative pathogens. In addition, external ventricular drainage and intracerebral pressure monitoring catheter were risk factors for XDR. Survival analysis revealed that MDR bacteria colonization happens earlier (log-rank test p = 0.017).

conclusionsOptimization of healthcare strategies is required in order to reduce patients' length of stay to prevent multi- and extensively-drug gram-negative colonizations. Indeed, an early external ventricular drainage and intracerebral pressure monitoring catheter removal is deemed necessary as soon as clinically appropriate.

Indexed as

Anti-Bacterial AgentsIntensive Care UnitsAdultBacteriaGram-Negative BacteriaHumansLength of StayRetrospective StudiesRisk FactorsAnti-Bacterial AgentsExtensively drug resistantInfectionIntensive care unitMultidrug resistantRetrospective studyRisk factors

Identifiers

PMID33063159
OpenAlexW3093358665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.